Nanoparticle technology demonstrates selective destruction of leukemia cancer cells

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: A research team, affiliated with UNIST has developed nanoparticles that effectively treat acute myeloid leukemia (AML), offering the potential to reduce side effects while enhancing therapeutic efficacy by selectively targeting and eliminating leukemia cells. Jointly led by Professors Sebyung Kang, Eunhee Kim, and Sung Ho Park from the Department of Biological Sciences at UNIST, the research team created an AML-specific, apoptotic cell death-inducing protein nanoparticle,...